Omicron sub-variants cut potency of monoclonal antibodies, mRNA vaccines: study
Mar 04, 2022
Eli Lilly’s bebtelovimab is the only authorized monoclonal antibody that can neutralize all three dominant sub-variants, investigators say.
Vaccines protect against omicron’s fast-spreading sister variant, BA.2, new data show
Feb 01, 2022
COVID-19 vaccines will continue to protect the public against a spinoff omicron gene variant that’s making inroads across the United States, new data from the United Kingdom suggest.
CDC: Third shot raises mRNA vaccine efficacy against hospitalization for range of patients
Jan 31, 2022
Adults who receive a third dose of the Pfizer-BioNTech or Moderna vaccine are better protected against COVID-19 hospitalization than their peers who have received only two doses, and immunocompromised...
Can mRNA tech make a better shingles shot? Vaccine makers plan to find out
Jan 06, 2022
Pfizer and BioNTech plan to speed development of a prospective shingles drug, with clinical trials expected to begin in the second half of 2022.
Effectiveness of mRNA COVID-19 vaccines lower at ≥120 days
Dec 09, 2021
Among U.S. veterans, VE was 86 percent for Moderna and 75 percent for PfizerBioNTech vaccines at ≥120 days after the second dose
Rates of COVID-19, severe illness lower with BNT162b2 booster dose
Dec 09, 2021
Second study shows reduction in rate of death due to COVID-19 with booster dose of BNT162b2
FDA panel recommends COVID boosters for older adults, healthcare workers
Sep 20, 2021
An FDA advisory panel has unanimously recommended approving COVID-19 booster shots for adults aged 65 years and older and for individuals at high risk of severe disease, including healthcare workers.
Healthcare worker study shines light on who is most at risk of a vaccine reaction
Aug 26, 2021
A study in nearly 1,000 healthcare workers has pinpointed factors that may boost the odds of having a reaction to a COVID-19 mRNA vaccine.
Clinical briefs for Thursday, Aug. 12
Aug 12, 2021
Dental, hearing, vision coverage on ‘front burner’ as lawmakers eye Medicare expansion … CDC: Pregnant women should get vaccinated; SARS-CoV-2 infection linked to preterm births … European drug...
Second dose of mRNA vaccine is safe after acute allergic reaction to first, investigators say
Jul 27, 2021
The CDC has recommended that people who have a reaction to the Pfizer or Moderna vaccines take the Johnson & Johnson vaccine as a second shot. But the new study suggests that this “mixed” series of...